Editor-Curated Robotics Industry Briefing - RobotToday

Wandercraft Completes Acquisition of Ekso Bionics to Enhance Medical Exoskeleton Offerings

Wandercraft has acquired Ekso Bionics from a subsidiary of ChronoScale Holdings, merging their medical exoskeleton businesses to enhance rehabilitation and personal mobility solutions. This acquisition combines Wandercraft's robotics expertise with Ekso Bionics' established U.S. operations, expanding their market presence and support network. The merger is significant as it integrates two leading players in the medical exoskeleton sector, with products like Atalante X and EksoNR already utilized in over 700 rehabilitation centers globally. Both companies hold FDA clearances and CE markings for various neurological and mobility conditions, ensuring a robust portfolio for healthcare providers and patients. Looking ahead, Wandercraft aims to leverage this acquisition to broaden access to robotic mobility solutions, enhancing patient care and rehabilitation services. No further timeline was disclosed at the time of publication.